To view or add a comment, sign in Today in #Employer Coverage: CMS has indefinitely postponed its BALANCE program that would have subsidized #GLP-1 obesity medications for Medicare members, a predictable outcome given the adverse selection risks and short-term cost challenges that make coverage financially untenable for health plans even at negotiated prices
While ingredients like short-chain FOS can replicate some of this water-binding functionality, we recommend adding plant-based extracts, like our latest Rowanberry-based ingredients
Medications designed to help with blood sugar management, especially popular treatments like Ozempic or other semaglutides, can result in this condition, as can many others
By reducing the reward aspect of eating and making the person feel more full, the drugs may be able to treat binge eating
If you're in Bellevue or Redmond and want a training program that supports your GLP-1 results, our $99 three-week trial is a low-pressure way to start
Wegovy is a once-weekly subcutaneous injection from a single-dose pre-filled pen